DURECT (NASDAQ:DRRX)
2.09
0.02 (0.95%)
| DURECT (NASDAQ:DRRX) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $2.11 | 52 Week High | $4.26 | ||
| Open | $2.12 | 52 Week Low | $1.40 | ||
| Day High | $2.20 | P/E | N/A | ||
| Day Low | $2.06 | EPS | $-0.50 | ||
| Volume | 202,510 | ||||
| More DRRX Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| CNXT | 2 | STEC | 1 |
| AET | 1 | ARG | 1 |
| BELFB | 1 | CDI | 1 |
| CPF | 1 | DLR | 1 |
| EXAR | 1 | GFI | 1 |
| HTZ | 1 | KB | 1 |
Entities who have mentioned DRRX
- Morningstar, Inc. | View Related Stories »
- Trading Radar | View Related Stories »
- Piper Jaffray | View Related Stories »
- Deutsche Bank | View Related Stories »
- RBC Capital | View Related Stories »
- Goldman Sachs | View Related Stories »
- Citi | View Related Stories »
- Robert W Baird | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- UBS | View Related Stories »
- Morgan Stanley | View Related Stories »
View All Major News StreetInsider.com Major News for DRRX
- DURECT Corporation (DRRX) Reports Smaller-Than-Expected Loss on Higher Revenues
- DURECT Corporation (DRRX) Reports Mixed Q2 Resupts
- DURECT Corporation (DRRX) Misses Q1 View By 2c
View All ReportsStreetInsider.com Reports on DRRX
- DURECT Corporation (DRRX) Reports Smaller-Than-Expected Loss on Higher Revenues
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- DURECT (DRRX) Announces Sale of 4,444,444 Shares of Stock At $2.25 A Share
- DURECT (DRRX) Announces License of ADHD Drug Candidate in Selected Asian and South Pacific Countries to Orient Pharma
- DURECT Corporation (DRRX) Reports Mixed Q2 Resupts
View All Press ReleasesCompany Press Releases on DRRX
- DURECT Corporation Announces Third Quarter 2009 Financial Results
- DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
StreetInsider Reports on DRRX by Category
View All BlogsBlogs on DRRX
- Seven Bullish Stocks to Watch This Week
- Durect: Be Patient Investors, Better Times Are Ahead
- Biggest Healthcare Winners Become Biggest Losers After Friday's Market Action
- FDA and Clinical Trial Updates: United Therapeutics Faces Delays
- DURECT Corporation, Q4 2008 Earnings Call Transcript
Comments on DRRX
No comments are currently available.
